Towards the targeted management of hereditary gingival fibromatosis

Simple item page
dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorYussif N.M.
dc.contributor.authorAbdul Aziz M.A.
dc.contributor.otherOral Diagnosis
dc.contributor.otherMedicine & Periodontology Dept.
dc.contributor.otherFcaulty of dentistry-october university of modern science and arts (MSA)
dc.contributor.otherGiza
dc.contributor.otherEgypt; Oral and Maxillofacial Pathology Department
dc.contributor.otherFaculty of dentistry
dc.contributor.otherCairo University
dc.contributor.otherGiza
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:40:48Z
dc.date.available2020-01-09T20:40:48Z
dc.date.issued2018
dc.descriptionScopus
dc.description.abstractAlthough hereditary gingival fibromatosis is a rare condition, it leaves unrestroable psychological, esthetical as well as functional problems to the affected patients. The purpose of the current research is to find a non-surgical pharmacological mechanism that could provide a control of the active phase of such disease helping individual to continue their lives. � 2018 Elsevier Ltden_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=17833&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1016/j.mehy.2018.09.017
dc.identifier.doiPubMed ID : 30396478
dc.identifier.issn3069877
dc.identifier.otherhttps://doi.org/10.1016/j.mehy.2018.09.017
dc.identifier.otherPubMed ID : 30396478
dc.identifier.urihttps://t.ly/dOOl6
dc.language.isoEnglishen_US
dc.publisherChurchill Livingstoneen_US
dc.relation.ispartofseriesMedical Hypotheses
dc.relation.ispartofseries121
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectUniversity for Modern Sciences and Arts
dc.subjectMSA University
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subjectCalciumen_US
dc.subjectConnective tissueen_US
dc.subjectEpitheliumen_US
dc.subjectGingival fibromatosisen_US
dc.subjectVitamin Den_US
dc.subjectantiinfective agenten_US
dc.subjectcalciumen_US
dc.subjectvitamin Den_US
dc.subjectcalciumen_US
dc.subjectscatter factoren_US
dc.subjectsomatomedin Cen_US
dc.subjectvitamin Den_US
dc.subjectArticleen_US
dc.subjectclinical examinationen_US
dc.subjectdebridementen_US
dc.subjectdisease activityen_US
dc.subjectdisease controlen_US
dc.subjectgenetic disorderen_US
dc.subjectgenetic screeningen_US
dc.subjectgingiva fibromatosisen_US
dc.subjectgingival tissueen_US
dc.subjectgingivectomyen_US
dc.subjecthistopathologyen_US
dc.subjecthumanen_US
dc.subjectlaboratory testen_US
dc.subjectmouth examinationen_US
dc.subjectoral surgeryen_US
dc.subjectperiodontal procedureen_US
dc.subjectphysical examinationen_US
dc.subjectradiodiagnosisen_US
dc.subjectconnective tissueen_US
dc.subjectepitheliumen_US
dc.subjectgingivaen_US
dc.subjectgingiva fibromatosisen_US
dc.subjecthomeostasisen_US
dc.subjectmetabolismen_US
dc.subjectpathologyen_US
dc.subjectperiodontal diseaseen_US
dc.subjectCalciumen_US
dc.subjectConnective Tissueen_US
dc.subjectEpitheliumen_US
dc.subjectFibromatosis, Gingivalen_US
dc.subjectGingivaen_US
dc.subjectHepatocyte Growth Factoren_US
dc.subjectHomeostasisen_US
dc.subjectHumansen_US
dc.subjectInsulin-Like Growth Factor Ien_US
dc.subjectPeriodontal Diseasesen_US
dc.subjectVitamin Den_US
dc.titleTowards the targeted management of hereditary gingival fibromatosisen_US
dc.typeArticleen_US
dcterms.isReferencedByPappachan, B., Narayan, J., Nayak, A., Idiopathic gingival fibromatosis: a neglected case (2002) Head Neck, 12 (3), pp. 335-338; Anderson, J., Cunliffe, W., Roberts, D., Close, H., Hereditary gingival fibromatosis (1969) Br Med J, 26 (3(5664)), pp. 218-219; Carranza, F.A., Hogan, E.L., Gingival enlargement (2002) Clinical periodontology, pp. 279-296. , M.G. Newman H.H. Takei F.A. Carranza 10th ed. WB Saunders Co Philadelphia; Singhal, R., Rozra, S., Bhagol, A., Idiopathic gingival fibromatosis: review of literature and a case report (2013) J Oral Health Commun Dentistry, 7 (3), pp. 174-177; Kalluri, R., Neilson E Epithelial-mesenchymal transition and its implications for fibrosis (2003) J Clin Investig, 112 (12), pp. 1776-1784; Menga, L., Yea, X., Fan, M., Xiong, X., Von den Hoffb, J., Biana, Z., Keratinocytes modify fibroblast metabolism in hereditary gingival fibromatosis (2008) Arch Oral Biol, 53 (11), pp. 1050-1057; Kantarci, A., Sume, S., Black, S., Lee, A., Xydas, C., Hasturk, H., Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis: role of epithelial-mesenchimal transition) (2010) CCN proteins in health and disease: an overview of the Fifth International Workshop of the CCN family of genes, , A. Perbal M. Takigawa B.V. Perbal Springer; Araujo, C., Graner, E., Almeida, O., Sauk, J., Coletta, R., Histomorphometric characteristics and expression of epidermal growth factor and its receptor by epithelial cells of normal gingival and hereditary gingival fibromatosis (2003) J Periodontal Res, 38 (3), pp. 237-241; Smith, M., Crofoot, K., Rodriguez-Proteau, R., Filtz, T., Effects of phenytoin and carbamazepine on calcium transport in Caco-2 cells (2007) Toxicol In Vitro, 21, pp. 855-862; Doufexi, A., Mina, M., Ioannidou, E., Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review (2005) J Periodontol, 76 (1), pp. 3-10; Pisoschi, C., St?nciulescu, C., Andrei, A., Berbecaru-Iovan, A., Munteanu, C., Popescu, F., Bani?? I. Role of transforming growth factor ?�connective tissue growth factor pathway in dihydropyridine calcium channel blockers-induced gingival overgrowth (2014) Rom J Morphol Embryol, 55 (2), pp. 285-290; Valsecchi, R., Cainelli, T., Gingival hyperplasia induced by erythromycin (1992) Acta Derm Venereol, 72 (2), p. 157; Caron, F., Meurice, J., Dore, P., Perault, M., Breux, J., Patte, F., Gingival hyperplasia: a new side effect associated with trimethoprim-sulfamethoxazole (TML-SMX) treatment in pulmonary nocardiosis (1997) Therapie, 52 (1), pp. 73-74; Taylor, J., Simpson, R., Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse (1992) Cancer Res, 52, pp. 2413-2418; von Graffenried, B., Krupp, P., Side-effects of cyclosporine (Sandimmune) in renal transplant recipients and in patients with autoimmune diseases (1986) Transplant Proc, 18, pp. 876-883; Deshmukh, S., Dive, A., Moharil, R., Munde, P., Enigmatic insight into collagen (2016) J Oral Maxillofac Pathol, 20, pp. 276-283; Bostick, R.M., Fosdick, L., Wood, J.R., Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial (1995) J Natl Cancer Inst, 87, pp. 1307-1315; Rothstein, J., Kuncl, R., Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity (1995) J Neurochem, 65, pp. 643-651; Hallmon, W., Rossmann, J., The role of drugs in the pathogenesis of gingival overgrowth A collective review of current concepts (1999) Periodontology 2000, 21, pp. 176-196; Banita, M., Pisoschi, C., St?nciulescu, C., Mercu?, V., Scrieciu, M., Hancu, M., Phenytoin induced gingival overgrowth � an immunohistochemical study of TGF-?1 mediated pathogenic pathways (2011) Farmacia, 59 (1), pp. 24-34; Faridi, M., Aggarwal, A., Phenytoin induced vitamin D deficiency presenting as proximal muscle weakness (2010) Indian Pediatr, 47, p. 17; Drezner, M., Treatment of anticonvulsant drug-induced bone disease (2004) Epilepsy Behav, 5 (2), pp. S41-S47; Lans, J., Jaszewski, R., Arlow, F., Tureaud, J., Luk, G., Majumdar, A., Supplemental calcium suppresses colonic mucosal ornithine decarboxylase activity in elderly patients with adenomatous polyps (1991) Cancer Res, 51, pp. 3416-3419; Thomas, M., Thomson, J., Williamson, R., Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis (1993) Br J Surg
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
avatar_scholar_128.png
Size:
2.73 KB
Format:
Portable Network Graphics
Description:
Download

Collections

Faculty Of Dentistry Research Paper